Structure, function and role of lipoprotein lipase in lipoprotein metabolism

Current Opinion in Lipidology

Volumn 5, Issue 2, 1994, Pages 117-125

  Santamarina Fojo, Silvia ^a   Dugi, Klaus A ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME VARIANT; LIPOPROTEIN LIPASE; LIPOPROTEIN RECEPTOR; TRIACYLGLYCEROL;

ATHEROSCLEROSIS; CELL SURFACE; ENZYME MECHANISM; ENZYME STRUCTURE; HUMAN; HYDROLYSIS; HYPERLIPIDEMIA; LIPID METABOLISM; LIPOPROTEIN METABOLISM; PRIORITY JOURNAL; RECEPTOR BINDING; REVIEW;

EID: 0028327343     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041433-199404000-00008     Document Type: Review

References (85)

1. SANTAMARINA-FOJO S. Genetic Dyslipoproteinemias: Role of Lipoptotein Lipase and Apolipoprotein C-H. Curr Opin Lipidol 1992, 3:186-195.
2. OLIVECRONA T, BENGTSSON-OLIVECRONA G. Lipoprotein Lipase and Hepatic Lipase. Curr Opin Lipidol 1993, 4:187-196. Excellent review of LPL structure and intracellular processing factors reg-ulating LPL gene expression
3. LALOUEL J-M, WILSON DE, IVERIUS P-H: Lipoprotein Lipase and Hepatic Triglyceride Lipase: Molecular and Genetic Aspects. Curr Opin Lipidol 1992, 3:86-95. This review provides an update of the molecular basis of LPL and HL deficiency.
4. SANTAMARINA-FOJO S, BREWER HB JR: The Familial Hyperchylomicronemia Syndrome. New Insights into Underlying Genetic Defects. JAMA 1991, 265:904-908
5. GAGNE C, BRUM LD, JULIEN P, MOORJANI S, LUPIEN PJ: Primary Lipoprotein Lipase Activity Deficiency: Clinical Investigation of a French Canadian Population Can Med Assoc J 1989, 140:405-411.
6. CHIMIENTI G, CAPURSO A, RESTA F, PEPE G: A G→C Change at the Donor Splice Site of Intron I Causes Lipoprotein Lipase Deficiency in a Southern-Italian Family. Biochem Biophys Res Commun 1992, 187:620-627.
7. WILSON DE, HATA A, KWONG LK, LINGAM A, SHUHUA J, RIDINGER DN, YEAGER C, KALTENBORN KC, IVERIUS PH, LALOUEL JM. Mutations in Exon 3 of the lipoprotein Lipase Gene Segregating in a Family with Hypertriglceridemia, Pancreatitis and Non-Insulin-Dependent Diabetes. J Clin Invest 1993, 92:203-211
8. 916) in Exon 5 of LPL Gene Causes no Detectable LPL Protein Due to the Absence of LPL mRNA Transcript J Clin Invest 1992, 89:581-591.
9. 64 →Nonsense Mutation in the Lipoprotein Lipase Gene. J Lipid Res 1992, 33:859-866.
10. HATA A, RIDINGER DN, SUTHERLAND SD, EMI M, KWONG LK, SHUHUA J, LUBBERS A, GUT-GRAND B, BASDEVANT A, IVERIUS P-H, WILSON DE, LALOUEL J-ML: Missense Mutations in Exon 5 of the Human Lipoprotein Lipase Gene. Inactivation Correlates with Loss of Dimerization. J Biol Chem 1992, 267:20132-20139. Preliminary evidence that the mechanism of LPL inactivation by some exon 5 LPL gene mutations involves disruption of LPL dimer formation and/or subunit assembly
11. 250→Asn) in Exon 6 of the Human Lipoprotein Lipase Gene Causes Chylomicronemia in Patients of Different Ancestries. Genomics 1992, 13:649-653.
12. 250→Asn) Mutation in the Lipoprotein Lipase Gene in Two Unrelated Families With Familial Lipoprotein Lipase Deficiency. J Lipid Res 1992, 33:745-754.
13. KOBAYASHI J, NISHIDA T, AMEIS D, STAUNKE G, SCHOTZ MC, HASHIMOTO H, FUKAMACHI I, SHIRAI K, SAITO Y, YOSHIDA S: A Heterozygous Mutations (the Codon for Ser447-a Stop Codon) in Lipoprotein Lipase Contributes to a Defect in Lipid Interface Recognition in a Case with Type I Hyperlipidemia. Biochem Biophys Res Commun 1992, 182:70-77.
14. 334→Thr) in Exon 7 of the Lipoprotein Lipase Gene in a Case with Type I Hyperlipidemia. Biochem Biophys Res Commun 1993, 191.1046-1054.
15. PREVIATO L, GUARDAMAGNA O, BRUNZELL JD, SANTAMARINA-FOJO S, BREWER HB JR: A Novel Missense Mutation in the Carboxyl Terminal Domain of Lipoprotein Lipase Leads to Enzyme Inactivation. Circulation 1992, 86:1-608.
16. GINZINGER DG, MA Y, LIU MS, HARVEY-CLARKE C, BRUNZELL JD, HAYDEN MR: Molecular Characterization of Lipoprotein Lipase Deficiency in the Cat: An Animal Model for Human Lipoprotein Lipase Deficiency [Abstract]. Circulation 1993, 88:1-268 Characterization of one of the few functional mutations in the carboxyl-terminal domain of LPL suggests an important role of the carboxyl-terminal domain in LPL dimer formation or stability.
17. WINKLER FK, D'ARCY A, HUNZIKER W. Structure of Human Pancreatic Lipase. Nature 1990, 343:771-774.
18. EMMERICH J, BEG OU, PETERSON J, PREVIATO L, BRUNZELL JD, BREWER HB JR, S. SANTAMARINA-FOJO: Human Lipoprotein Lipase. Anaylsis of the Catalytic Triad by Site-Directed Mutagenesis of Ser-132, Asp-156 and His-241. J Biol Chem 1992, 267:4161-4165.
19. FAUSTINELLA F, SMITH LC, SEMENKOVICH CF, CHAN L: Structural and Functional Holes of Highly Conserved Serines in Human Lipoprotein Lipase. J Biol Chem 1991, 266:9481-9485.
20. WONG H, DAVIS RC, NIKAZY J, SEEBART KE, SCHOTZ MC: Domain Exchange: Characterization of a Chimeric Lipase of Hepatic Lipase and Lipoprotein Lipase. Proc Natl Acad Sci USA 1991, 88:11290-11294.
21. DAVIS RC, WONG H, NIKAZY J, WANG K, HAN Q, SCHOTZ MC: Chimeras of Hepatic Lipase and Lipoprotein Lipase. Domain Localization of Enzyme-Specific Properties. J Biol Chem 1992, 267:21499-21504. Characterization of LPL and HL chimeras engineered from rat and human sequences localizes the catalytic function and site of apoC-II interaction to the amino-terminal domain of the lipase, as well as indicates an important role of the carboxyl-terminal domain in lipase-substrate interaction.
22. DICHEK HL, PARROTT C, RONAN R, BRUNZELL JD, BREWER HB JR, SANTAMARINA-FOJO S: Functional Characterization of a Chimeric Protein Genetically Engineered from Human Lipoprotein Lipase and Human Hepatic Lipase. J Lipid Res 1993, 34:1393-1401. Similar chimera study which identifies the structural location of diffrent LPL functional domains. In addition, the study indicates that heparin-binding involves both amino- and carboxyl-terminal domains of LPL.
23. BRUIN T, VAN DER SLUIS BEM, KASTELEIN JJP: Identification of the Apo-CII Binding Site on Human Lipoprotein Lipase. Circulation 1992, 86:1-608.
24. YANG C, GU YZW, YANG H-Y, ROHDE MF, GOTTO AM JR, POWNALL HJ: Structure of Bovine Milk Lipoprotein Lipase. J Biol Chem 1989, 264:16822-16827.
25. BERRYMAN DE, BENSADOUN A: Site-Directed Mutagenesis of a Putative Heparin Binding Domain of Avian Lipoprotein Lipase. J Biol Chem 1993, 268:3272-3276. Identification of potential heparin binding sites within avian LPL.
26. HATA A, RIDINGER DN, SUTHERLAND S, EMI M, SHUHUA Z, MYERS RL, REN K, CHENG T, INOUE I, WILSON DE, IVERIUS P-H, LALOUEL J-M: Binding of Lipoprotein Lipase to Heparin. Identification of Five Critical Residues in Two Distinct Segments of the Amino-Terminal Domain. J Biol Chem 1993, 268:8447-8457. Studies involving site-directed mutagenesis identify basic residues in human LPL involved in heparin binding
27. LOOKENE A, BENGTSSON-OLIVECRONA G. Chymotryptic Cleavage of Lipoprotein Lipase-Identification of Cleavage Sites and Functional Studies of the Truncated Molecule. Eur J Biochem 1993, 213:185-194. The authors localize the site of chylomicron binding to the carboxyl-terminal 56 residues of LPL.
28. DUGI KA, DICHEK HL, TALLEY GD, BREWER HB JR, SANTAMARINA-FOJO S: Human Lipoprotein Lipase: The Loop Covering the Catalytic Site is Essential for Interaction with Lipid Substrates. J Biol Chem 1992, 267:25086-25091. Identification of two amphipathic helices in the lid of LPL and HL. Site-directed mutagenesis of these helices establishes a crucial role of the helices and LPL lid in lipase-lipid substrate interaction.
29. HENDERSON HE, MA Y, LIU MS, CLARK-LEWIS I, MAEDER DL, KASTELEIN JJP, BRUNZELL JD, HAYDEN MR: Structure-Function Relationships of Lipoprotein Lipase: Mutation Analysis and Mutagenesis of the Loop Region. J Lipid Res 1993, 34:1593-1602
30. DUGI KA, DICHEK HL, BREWER HB JR, FOJO SS: New Insights into the Structural Basis for the Different Substrate Specificities of Hepatic Lipase and Lipoprotein Lipase [Abstract]. Circulation 1993, 88:1-178. An important study establishing a role for the lipase lid in determining lipase substrate specificity.
31. VAN TILBEURGH H, EGLOFF MP, MARTINEZ C, RUGANI N, VERGER R, CAMBILLAU C: Interfacial Activation of the Lipase-Procolipase Complex by Mixed Micelles Revealed by X-Ray Crystallography Nature 1993, 362:814-820. The elucidation of the three-dimensional crystallographic structure of pancreatic lipase in the presence of colipase and lipid-micelles provides new insights into structural changes occurring during interfacial activation and hydrolysis of the lipid substrates by pancreatic lipase.
32. BRZOZOWSKI AM, DEREWENDA U, DEREWENDA ZS, DODSON GG, LAWSON DM, TURKENBURG JP, BJORKLING F, HUGE-JENSEN B, PATKAR SA, THIM L: A Model for Interfacial Activation in Lipases from the Structure of a Fungal lipase-Inhibitor Complex. Nature 1991, 351:491-494.
33. DEREWENDA U, BRZOZOWSKI AM, LAWSON DM, DEREWENDA ZS: Catalysis at the Interface: The Anatomy of a Conformational Change in a Triglyceride Lipase. Biochemistry 1992, 31:1532-1541.
34. GROCHULSKI P, LI Y, SCHRAG JD, BOUTHILLIER F, SMITH P, HARRISON D, RUBIN B, CYGLER M: Insights into Interfacial Activation from an Open Structure of Candida rugosa Lipase J Biol Chem 1993, 268:12843-12847.
35. TASHIRO J, KOBAYASHI J, SHIRAI K, SAITO Y, NAKAMURA H, MORIMOTO Y, YOSHIDA S. Trypsin Treatment may Impair the Interfacial Activation Action of Lipoprotein Lipase. J Biochem 1992, 111-509-514.
36. MARTINEZ C, DE GEUS P, LAUWEREYS M, MATTHYSSENS G, CAMBILLAU C: Fusarium Solani Cutinase is a Lipolytic Enzyme with a Catalytic Serine Accessible to Solvent. Nature 1992, 356:615-618.
37. HJORTH A, CARRIERE F, CUDREY C, WOELDIKE H, BOEL E, LAWSON DM, FERRATO F, CAMBILLAU C, DODSON GD, THIM L, VERGER R. A Structural Domain (the Lid) Found in Pancreatic Lipases is Absent in the Guinea Pig (Phospho)lipase Biochemistry 1993, 32:4702-4707.
38. FELTS JM, ITAKURA H, CRANE RT: The Mechanism of Assimilation of Constituents of Chylomicrons, Very Low Density lipoproteins and Remnants - a New Theory. Biochem Biophys Res Commun 1975, 66:1467-1475.
39. BEISIEGEL U, WEBER W, BENGTSSON-OLIVECRONA G: Lipoprotein Lipase Enhances the Binding of Chylornicrons to Low Density Lipoprotein Receptor-Related Protein Proc Natl Acad Sci USA 1991, 88:8342-8346
40. CHENG CF, OOSTA GM, BENSADOUN A, ROSENBERG RD: Binding of Lipoprotein Lipase to Endothelial Cells in Culture. J Biol Chem 1993, 256:12893-12898.
41. SHIMADA K, LANZILLO JJ, DOUGLAS WH, FANBURG BL: Stabilization of Lipoprotein Lipase by Endothelial Cells. Biochim Biophys Acta 1993, 710:117-121
42. GOLDBERG IJ, KANDEL JJ, BLUM CB, GINSBERG HN. Association of Plasma Lipoproteins with Postheparin Lipase Activities J Clin Invest 1986, 78:1523-1528
43. VILELLA E, JOVEN J: Lipoprotein Lipase Binding to Plasma Lipoproteins. Med Sci Res 1991, 19:111-112
44. EISENBERG S, SEHAYEK E, OLIVECRONA T, VLODAVSKY I: Lipoprotein Lipase Enhances Binding of Lipoproteins to Heparan Sulfate on Cell Surfaces and Extracellular Matrix J Clin Invest 1992, 90:2013-2021.
45. 2-Macroglobulin Receptor/Low Density Lipoprotein Receptor-Released Protein Binds Lipoprotein Lipase and -Migrating Very Low Density Lipoprotein Associated with the Lipase. J Biol Chem 1993, 268:15048-15055. Provides further evidence for the role of LPL as a ligand for LRP and characterizes the structural and functional properties of LPL required for binding to both VLDL and LRP.
46. MULDER M, LOMBARDI P, JANSEN H, VAN BERKEL TJC, FRANTS RR, HAVEKES LM: Heparan Sulphate Proteoglycans are Involved in the Lipoprotein Lipase-Mediated Enhancement of the Cellular Binding of Very Low Density and Low Density Lipoproteins. Biochem Biophys Res Commun 1992, 185:582-587.
47. MULDER M, LOMBARDI P, JANSEN H, VAN BERKEL TJC, FRANTS RR, HAVEKES LM: Low Density Lipoprotein Receptor Internalizes Low Density and Very Low Density Lipoproteins that are Bound to Heparan Sulfate Proteoglycans via Lipoprotein Lipase J Biol Chem 1993, 268:9369-9375.
48. 2-Macroglobulin Receptor in Vitro. J Biol Chem 1993, 268:14168-14175.
49. RUMSEY SC, OBUNIKE JC, ARAD Y, DECKELBAUM RH, GOLDBERG IJ. Lipoprotein Lipase-Mediated Uptake and Degradation of Low Density Lipoproteins by Fibroblasts and Macrophages. J Clin Invest 1992, 90:1504-1512.
50. WILLIAMS KJ, FLESS GM, PETRIE KA, SNYDER ML, BROCIA RW, SWENSON TL: Mechanisms by Which Lipoprotein Lipase Alters Cellular Metabolism of Lipoprotein (a), Low Density Lipoprotein and Nascent Lipoproteins. Roles for Low Density Lipoprotein Receptors and Heparan Sulfate Proteoglycans. J Biol Chem 1992, 267 13284-13292. Evidence for LPL-stimulated lipoprotein uptake and degradation by the LDL receptor and for a role of proteoglycans in the initial interaction of LPL with cell surfaces.
51. 2-Macroglobulin Receptor Binds and Mediates Catabolism of Bovine Milk Lipoprotein Lipase. J Biol Chem 1992, 267:25764-25767
52. WILLNOW TE, GOLDSTEIN JL, ORTH K, BROWN MS, HERZ J. Low Density Lipoprotein Receptor-Related Protein and gp330 Bind Similar Ligands, Including Plasminogen Activator-Inhibitor Complexes and Lactoferrin, an Inhibitor of Chylomicron Remnant Clearance. J Biol Chem 1992, 267:26172-26180.
53. MANN A, MEYER N, WEBER W, RINNINGER F, GRETEN H, BEISIEGEL U Coordinate Effect of Apolipoprotein E and Lipoprotein Lipase on Binding of Lipoproteins to Cells [Abstract]. Circulation 1993, 88:1-321
54. AL-HAIDERI M, GRANOT E, SCHWIEGELSHOHN B, VOGEL T, GORECKI M, GOLDBERG IJ, DECKELBAUW RJ. Apoprotein E Stimulates Non-Receptor Triglyceride-Rich Particle Cellular Uptake [Abstract]. Circulation 1993, 88:1-321.
55. LAUER SJ, JI Z-S, FAZIO S, BENSADOUN A, TAYLOR JM, MAHLEY RW: Human Hepatic Lipase Secretion by Transfected McA-RH7777 Cells Results in Enhanced Binding and Uptake of Remnant Lipoproteins [Abstract]. Circulation 1993, 88:1-321.
56. Rouis M, PREVIATO L, GOLDBERG IJ, GINSBERG H, BRUNZELL JD, BREWER HB JR, SANTAMARINA-FOJO S: Unique Therapeutic Response to Medium Chain Triglycerides and Omega-3-Fatty Acids in Two Patients with Familial Chylomicronemia [Abstract]. Circulation 1993, 88:1-76.
57. SHIRAI K, KOBAYASHI J, INADERA H, OHKUBO Y, MORI S, SAITO Y, YOSHIDA S: Type I Hyperlipoproteinemia Caused by Lipoprotein Lipase Defect in Lipid-Interface Recognition was Relieved by Administration of Medium-Chain Triglyceride. Metab Clin Exp 1992, 41:1161-1164. Characterization of the unique response of a patient with LPL deficiency to treatment with medium-chain triglyceride oil.
58. WATTS GF, MORTON K, JACKSON P, LEWIS; Management of Patients with Severe Hypertriglyceridaemia During Pregnancy: Report of Two Cases with Familial Lipoprotein Lipase Deficiency. Br J Obstet Gyneacol 1992, 99:163-166.
59. 172-Cys Mutation in the Lipoprotein Lipase Gene. J Clin Invest 1993, 91:1953-1958.
60. WILSON DE, EMI M, IVERIUS P-H, HATA A, WU LL, HILLAS E, WILLIAMS RR, LALOUEL J-M: Phenotypic Expression of Heterozygous Lipoprotein Lipase Deficiency in the Extended Pedigree of a Proband Homozygous for a Missense Mutation. J Clin Invest 1990, 86735-750.
61. BABIRAK SP, BROWN BG, BRUNZELL JD: Familial Combined Hyperlipidemia and Abnormal Lipoprotein Lipase. Arteriosclerosis Thromb 1992, 12:1176-1183.
62. MIESENBOECK G, HOELZL B, FOEGER B, BRANDSTAETTER E, PAULWEBER B, SANDHOFER F, PATSCH JR: Heterozygous Lipoprotein Lipase Deficiency Due to a Missense Mutation as the Cause of Impaired Triglyceride Tolerance with Multiple Lipoprotein Abnormalities. J Clin Invest 1993, 91:448-455
63. CHAIT A, BRUNZELL JD: Severe Hypertriglyceridemia: Role of Familial and Acquired Disorders. Metabolism 1993, 32:209-214.
64. ZAMBON A, TORRES A, BIJVOET S, GAGNE C, MOORJANI S, LUPIEN PJ, HAYDEN MR, BRUNZELL JD: Prevention of Raised Low-Density Lipoprotein Cholesterol in a Patient with Familial Hypercholesterolaemia and Lipoprotein Lipase Deficiency. Lancet 1993, 341:1119-1121
65. ZILVERSMIT DB: A Proposal Linking Atherogenesis to the Interaction of Endothelial Lipoprotein Lipase with Triglyceride-Rich Lipoproteins. Circ Res 1973, 33:633-638.
66. CHAIT A, IVERIUS P-H, BRUNZELL JD. Lipoprotein Lipase Secretion by Human Monocyte-Derived Macrophages. J Clin Invest 1982, 69:490-493.
67. HERTTUALA SY, LIPTON BA, ROSENFELD ME, GOLDBERG IJ, STEINBERG D, WITZTUM JL: Macrophages and Smooth Muscle Cells Express Lipoprotein Lipase in Human and Rabbit Atherosclerotic Lesions. Proc Natl Acad Sci USA 1991, 88 10143-10147.
68. O'BRIEN KD, GORDON D, DEEB S, FERGUSON M, CHAIT A: Lipoprotein Lipase is Synthesized by Macrophage-Derived Foam Cells in Human Coronary Atherosclerotic Plaques. J Clin Invest 1992, 89:1544-1550.
69. SAXENA U, KLEIN MG, GOLDBERG IJ: Identification and Characterization of the Endothelial Cell Surface Lipoprotein Lipase Receptor J Biol Chem 1991, 266:17516-17521
70. SIVARAM P, KLEIN MG, GOLDBERG IJ: Identification of a Heparin-Releasable Lipoprotein Lipase Binding Protein from Endothelial Cells. J Biol Chem 1992, 267:16517-16522. Identification of a heparin-releasable, high-affinity 116kDa LPL binding protein that may mediate the binding, internalization and recycling of LPL by endothelial cells
71. STINS MF, MAXFIELD FR, GOLDBERG IJ Polarized Binding of Lipoprotein Lipase to Endothelial Cells: Implications for its Physiological Actions. Arteriosclerosis Thromb 1992, 12:1437-1446.
72. SAXENA U, KLEIN MG, VANNI TM, GOLDBERG IJ: Lipoprotein Lipase Increases Low Density Lipoprotein Retention by Subendothelial Cell Matrix. J Clin Invest 1992, 89:373-380. Evidence for LPL-mediated enhanced retention of LDL and VLDL to the subendothelial matrix
73. SAXENA U, FERGUSON E, AUERBACH BJ, BISGAIER CL. Lipoprotein Lipase Facilitates Very Low Density Lipoprotein Binding to the Subendothelial Cell Matrix. Biochem Biophys Res Commun 1993, 194:769-774.
74. SAXENA U, FERGUSON E, BISGAIER CL: Apolipoprotein E Modulates Low Density Lipoprotein Retention by Lipoprotein Lipase Anchored to the Subendothelial Matrix J Biol Chem 1993, 268:14812-14819. The data presented suggest that apoE and apoE-containing HDL reduce lipase-mediated retention of LDL by the subendothelial matrix.
75. LINDQVIST P, OSTLUND-LINDQVIST AM, WITZTUM JL, STEINBERG D, LITTLE JA: The Role of Lipoprotein Lipase in the Metabolism of Triglyceride-Rich Lipoproteins by Macrophages. J Biol Chem 1993, 258:9086-9092.
76. SOFER O, FAINARU M, SCHAFER Z, GOLDMAN R: Regulation of Lipoprotein Lipase Secretion in Murine Macrophages During Foam Cell Formation in vitro: Effect of Triglyceride-Rich Lipoproteins. Arteriosclerosis Thromb 1992, 12:1458-1466.
77. EVANS AJ, SAWYEZ CG, WOLTE BM, CONNELLY PW, MAGUIRE FG, HUFF MW Evidence that Cholesteryl Ester and Triglyceride Accumulation in J774 Macrophages Induced by Very Low Density Lipoprotein Subfractions Occurs by Different Mechanisms. J Lipid Res 1993, 34703-717.
78. STEIN O, BEN-NAIM M, DABACH Y, HOLLANDER G, HALPERIN G, SIEIN Y: Can Lipoprotein Lipase be the Culprit in Cholesteryl Ester Accretion in Smooth Muscle Cells in Atheroma? Atherosclerosis 1993, 99:15-22
79. SKARLATOS SI, DICHEK HL, SANTAMAHINA-FOJO S, BREWER HB JR, KRUTH HS: Absence of Triglyceride Accumulation in Lipoprotein Lipase-Deficient Human Monocyte-Macrophages Incubated with Human Very Low Density Lipoprotein J Clin Endocrinol Metab 1993, 76:793-796.
80. TABAS I, LI Y, BROCIA RW, XU SW, SWENSON TL, WILLIAMS KJ: Lipoprotein Lipase and Sphingomyelinase Synergistically Enhance the Association of Atherogenic Lipoproteins with Smooth Muscle Cells and Extracellular Matrix. J Biol Chem 1993, 268:20419-20432. The data presented support a cooperative role of LPL and sphingomyelinase in promoting atherosclerosis via retention of atherogenic lipoproteins.
81. SAXENA U, KULKARNI NM, FERGUSON E, NEWTON RS. Lipoprotein Lipase-Mediated Lipolysis of Very Low Density Lipoproteins Increases Monocyte Adhesion to Aortic Endothelial Cells. Biochem Biophys Res Commun 1992, 189:1653-1658.
82. RENIER G, SKAMENE E, DESANCTIS JB, RADZIOCH D: High Macrophage Lipoprotein Lipase Expression and Secretion are Associated in Inbred Murine Strains with Susceptibility to Atherosclerosis. Arteriosclerosis Thromb 1993, 13:190-196. The authors demonstrate an association between high levels of LPL expression in macrophages and susceptibility to atherosclerosis in certain murine strains, suggesting a contributive role of LPL in the development of atherosclerosis.
83. SHIMADA M, SHIMANO H, GOTODA T, YAMAMOTO K, KAWAMURA M, INABA T, YAZAKI Y, YAMADA N- Overexpression of Human Lipoprotein Lipase in Transgenic Mice. J Biol Chem 1993, 268:17924-17929. Overexpression of human LPL in Transgenic mice results in enhanced clearance of triglyceride-rich lipoproteins and resistance to diet-induced hypertriglyceridemia and hypercholesterolemia.
84. HAYDEN MR, LIU MS, JIRIK F, MA Y, LEBOUEF R, BRUNZELL JD: Expression of Human Lipoprotein Lipase in Transgenic Mice. J Cell Biochem 1993, 17E:242.
85. TSUTSUMI K, INOUE Y, SHIMA A, IWASAKI K, KAWAMURA M, MURASE T The Novel Compound NO-1886 Increases Lipoprotein Lipase Activity with Resulting Elevation of High Density and Long-Term Administration Inhibits Atherogenesis in the Coronary Arteries of Rats with Experimental Atherosclerosis. J Clin Invest 1993, 92:411-417. A chemically mediated increase in systemic LPL activity leads to elevated HDL levels and protection against the development of coronary artery lesions in rats.